BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

924 related articles for article (PubMed ID: 9219533)

  • 1. Formation of the early-region-2 transcription-factor-1-retinoblastoma-protein (E2F-1-RB) transrepressor and release of the retinoblastoma protein from nuclear complexes containing cyclin A is induced by interferon alpha in U937V cells but not in interferon-alpha-resistant U937VR cells.
    Kirch HC; Putzer B; Brockmann D; Esche H; Kloke O
    Eur J Biochem; 1997 Jun; 246(3):736-44. PubMed ID: 9219533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-alpha inhibits cyclin E- and cyclin D1-dependent CDK-2 kinase activity associated with RB protein and E2F in Daudi cells.
    Zhang K; Kumar R
    Biochem Biophys Res Commun; 1994 Apr; 200(1):522-8. PubMed ID: 8166726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation.
    Xu M; Sheppard KA; Peng CY; Yee AS; Piwnica-Worms H
    Mol Cell Biol; 1994 Dec; 14(12):8420-31. PubMed ID: 7969176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
    Kiess M; Gill RM; Hamel PA
    Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functions of cyclin A1 in the cell cycle and its interactions with transcription factor E2F-1 and the Rb family of proteins.
    Yang R; Müller C; Huynh V; Fung YK; Yee AS; Koeffler HP
    Mol Cell Biol; 1999 Mar; 19(3):2400-7. PubMed ID: 10022926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of E2F-1 by cyclin A-cdk2.
    Kitagawa M; Higashi H; Suzuki-Takahashi I; Segawa K; Hanks SK; Taya Y; Nishimura S; Okuyama A
    Oncogene; 1995 Jan; 10(2):229-36. PubMed ID: 7838523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A model of the G1 phase of the cell cycle incorporating cyclin E/cdk2 complex and retinoblastoma protein.
    Obeyesekere MN; Herbert JR; Zimmerman SO
    Oncogene; 1995 Sep; 11(6):1199-205. PubMed ID: 7566981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C/EBPalpha regulates formation of S-phase-specific E2F-p107 complexes in livers of newborn mice.
    Timchenko NA; Wilde M; Darlington GJ
    Mol Cell Biol; 1999 Apr; 19(4):2936-45. PubMed ID: 10082561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity.
    Khleif SN; DeGregori J; Yee CL; Otterson GA; Kaye FJ; Nevins JR; Howley PM
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4350-4. PubMed ID: 8633069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes.
    Lundberg AS; Weinberg RA
    Mol Cell Biol; 1998 Feb; 18(2):753-61. PubMed ID: 9447971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of retinoblastoma mediated signaling to Cdk2 results in cell cycle arrest.
    Strobeck MW; Fribourg AF; Puga A; Knudsen ES
    Oncogene; 2000 Apr; 19(15):1857-67. PubMed ID: 10773875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for a p21-E2F interaction during senescence arrest of normal human fibroblasts.
    Afshari CA; Nichols MA; Xiong Y; Mudryj M
    Cell Growth Differ; 1996 Aug; 7(8):979-88. PubMed ID: 8853893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rb and E2F-1 regulate telomerase activity in human cancer cells.
    Crowe DL; Nguyen DC
    Biochim Biophys Acta; 2001 Mar; 1518(1-2):1-6. PubMed ID: 11267653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit.
    Hofmann F; Livingston DM
    Genes Dev; 1996 Apr; 10(7):851-61. PubMed ID: 8846921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo.
    Ezhevsky SA; Ho A; Becker-Hapak M; Davis PK; Dowdy SF
    Mol Cell Biol; 2001 Jul; 21(14):4773-84. PubMed ID: 11416152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulation of specific E2F complexes by the v-mos oncogene.
    Afshari CA; Rhodes N; Paules RS; Mudryj M
    Oncogene; 1997 Jun; 14(25):3029-38. PubMed ID: 9223666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
    Morris L; Allen KE; La Thangue NB
    Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Rb-related p107 protein can suppress E2F function independently of binding to cyclin A/cdk2.
    Smith EJ; Nevins JR
    Mol Cell Biol; 1995 Jan; 15(1):338-44. PubMed ID: 7799940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells.
    Oh M; Choi YH; Choi S; Chung H; Kim K; Kim SI; Kim DK; Kim ND
    Int J Oncol; 1999 May; 14(5):869-75. PubMed ID: 10200336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F.
    Leone G; DeGregori J; Sears R; Jakoi L; Nevins JR
    Nature; 1997 May; 387(6631):422-6. PubMed ID: 9163430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.